Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial

Autor: Schechter, Meir, Wiviott, Stephen D, Raz, Itamar, Goodrich, Erica L, Rozenberg, Aliza, Yanuv, Ilan, Murphy, Sabina A, Zelniker, Thomas A, Fredriksson, Martin, Johansson, Peter A, Leiter, Lawrence A, Bhatt, Deepak L, McGuire, Darren K, Wilding, John P H, Gause-Nilsson, Ingrid A M, Cahn, Avivit, Langkilde, Anna Maria, Sabatine, Marc S, Mosenzon, Ofri *
Zdroj: In The Lancet Diabetes & Endocrinology April 2023 11(4):233-241
Databáze: ScienceDirect